These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18065212)

  • 1. Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol.
    Taeusch HW; Dybbro E; Lu KW
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):243-9. PubMed ID: 18065212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan decreases surfactant inactivation in vitro.
    Lu KW; Goerke J; Clements JA; Taeusch HW
    Pediatr Res; 2005 Feb; 57(2):237-41. PubMed ID: 15585679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan with dextran added to therapeutic lung surfactants improves effectiveness in vitro and in vivo.
    Lu KW; Taeusch HW; Clements JA
    Exp Lung Res; 2013; 39(4-5):191-200. PubMed ID: 23638643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.
    Taeusch HW; Bernardino de la Serna J; Perez-Gil J; Alonso C; Zasadzinski JA
    Biophys J; 2005 Sep; 89(3):1769-79. PubMed ID: 15923228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of polymers and KL(4) peptide on surface activity of pulmonary surfactant lipids.
    Lu KW; Taeusch HW
    Biochim Biophys Acta; 2010 Jun; 1798(6):1129-34. PubMed ID: 20188696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ethylene glycol) enhances the surface activity of a pulmonary surfactant.
    Yu LM; Lu JJ; Chiu IW; Leung KS; Chan YW; Zhang L; Policova Z; Hair ML; Neumann AW
    Colloids Surf B Biointerfaces; 2004 Aug; 36(3-4):167-76. PubMed ID: 15276633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.
    Zasadzinski JA; Alig TF; Alonso C; Bernardino de la Serna J; Perez-Gil J; Taeusch HW
    Biophys J; 2005 Sep; 89(3):1621-9. PubMed ID: 16006630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan enhances the in vitro surface activity of dilute lung surfactant preparations and resists albumin-induced inactivation.
    Zuo YY; Alolabi H; Shafiei A; Kang N; Policova Z; Cox PN; Acosta E; Hair ML; Neumann AW
    Pediatr Res; 2006 Aug; 60(2):125-30. PubMed ID: 16864690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A freeze-fracture transmission electron microscopy and small angle x-ray diffraction study of the effects of albumin, serum, and polymers on clinical lung surfactant microstructure.
    Braun A; Stenger PC; Warriner HE; Zasadzinski JA; Lu KW; Taeusch HW
    Biophys J; 2007 Jul; 93(1):123-39. PubMed ID: 17416614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system].
    Koga Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonionic polymers reverse inactivation of surfactant by meconium and other substances.
    William Taeusch H; Lu KW; Goerke J; Clements JA
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1391-5. PubMed ID: 10228100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of hyaluronan in the pulmonary alveolus.
    Bray BA
    J Theor Biol; 2001 May; 210(1):121-30. PubMed ID: 11343436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct interactions between nitrous oxide and exogenous pulmonary surfactant in vitro.
    Sosnowski TR; Gradoń L; Marraro GA
    Exp Lung Res; 2004 Jun; 30(4):311-8. PubMed ID: 15204836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric surfactants in disperse systems.
    Tadros T
    Adv Colloid Interface Sci; 2009; 147-148():281-99. PubMed ID: 19041086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinematic viscosity of therapeutic pulmonary surfactants with added polymers.
    Lu KW; Pérez-Gil J; Taeusch H
    Biochim Biophys Acta; 2009 Mar; 1788(3):632-7. PubMed ID: 19366601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductions of phospholipase A(2) inhibition of pulmonary surfactant with hyaluronan.
    Iwanicki JL; Lu KW; Taeusch HW
    Exp Lung Res; 2010 Apr; 36(3):167-74. PubMed ID: 20334607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum.
    Lu KW; Pérez-Gil J; Echaide M; Taeusch HW
    Biochim Biophys Acta; 2011 Oct; 1808(10):2366-73. PubMed ID: 21741354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient exposure of pulmonary surfactant to hyaluronan promotes structural and compositional transformations into a highly active state.
    Lopez-Rodriguez E; Cruz A; Richter RP; Taeusch HW; Pérez-Gil J
    J Biol Chem; 2013 Oct; 288(41):29872-81. PubMed ID: 23983120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ethylene glycol) (PEG) enhances dynamic surface activity of a bovine lipid extract surfactant (BLES).
    Lu JJ; Yu LM; Cheung WW; Goldthorpe IA; Zuo YY; Policova Z; Cox PN; Neumann AW
    Colloids Surf B Biointerfaces; 2005 Mar; 41(2-3):145-51. PubMed ID: 15737540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adsorption of sodium dodecyl sulfate at the hydrophobic solid/aqueous solution interface in the presence of poly(ethylene glycol): dependence upon polymer molecular weight.
    Casford MT; Davies PB; Neivandt DJ
    Langmuir; 2006 Mar; 22(7):3105-11. PubMed ID: 16548564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.